微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 57.98% | -6.61% | -9.3% | 57/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 63.92% | 2.91% | -0.66% | 47/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 64.35% | 2.51% | 1.22% | 49/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 63.57% | 4.7% | 2.4% | 51/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 62.08% | 8.22% | -0.05% | 49/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 62.12% | -1.6% | -1.04% | 52/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 62.77% | -2.71% | 3.38% | 50/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 60.72% | -4.51% | 5.84% | 53/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 57.37% | -8.89% | -9.13% | 57/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 63.13% | -8.49% | -2.15% | 45/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 64.52% | -8.34% | 1.47% | 42/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 63.58% | -8.68% | 0.99% | 47/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 62.96% | -4.84% | -8.73% | 50/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 68.98% | 5.21% | -2% | 40/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 70.39% | 6.97% | 1.1% | 29/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 69.63% | 12.25% | 5.23% | 40/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 66.17% | 2% | 0.92% | 41/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 65.56% | -3.69% | -0.37% | 55/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 65.81% | 2% | 6.08% | 37/131 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 62.03% | 2% | -8.88% | 53/131 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 68.07% | -3.63% | -3.63% | 38/131 | 56.37% | 正海生物 | 94.38% | 行业排名> |
| 2018-12-31 | 70.63% | 1.31% | 1.31% | 32/131 | 55.53% | 正海生物 | 93.12% | 行业排名> |
| 2017-12-31 | 69.72% | 2% | 2% | 30/131 | 55.34% | 正海生物 | 93.78% | 行业排名> |